Neuromedin U ‘innervation’ reprograms myeloid immunosuppression in neuroendocrine prostate cancer

Overview of attention for article published in Oncogene, September 2026

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,544 followers.

RT @oncogenejournal: New research identifies Neuromedin U (NMU) as a key driver of immune suppression in neuroendocrine prostate cancer. Re…

New research identifies Neuromedin U (NMU) as a key driver of immune suppression in neuroendocrine prostate cancer. Read now. https://t.co/TZsMRkcMNR

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.